Ghana’s preparedness to exploit the medicinal value of industrial hemp

Abstract Background Interest in industrial hemp is increasing steadily, as can be seen by the growing number of countries that have either decriminalized industrial hemp or are contemplating its decriminalization. In line with this trend, Ghana recently decriminalized the cultivation of industrial h...

Full description

Bibliographic Details
Main Author: Richard Quansah Amissah
Format: Article
Language:English
Published: BMC 2022-11-01
Series:Journal of Cannabis Research
Subjects:
Online Access:https://doi.org/10.1186/s42238-022-00167-4
_version_ 1828094973092823040
author Richard Quansah Amissah
author_facet Richard Quansah Amissah
author_sort Richard Quansah Amissah
collection DOAJ
description Abstract Background Interest in industrial hemp is increasing steadily, as can be seen by the growing number of countries that have either decriminalized industrial hemp or are contemplating its decriminalization. In line with this trend, Ghana recently decriminalized the cultivation of industrial hemp (the cannabis variety with low Δ9-tetrahydrocannabinol (THC) and high cannabidiol (CBD) content), resulting in the need for research into its benefits to Ghanaians. This article examines cannabis (including industrial hemp) production, facilities for industrial hemp exploitation, and the potential benefits of industrial hemp in Ghana. Main body Indigenous cannabis strains in Ghana have high THC to CBD ratios suggesting the need for the government to purchase foreign hemp seeds, considering that the alternative will require significant research into decreasing the THC to CBD ratio of indigenous cannabis strains. Furthermore, there are several facilities within the country that could be leveraged for the production of medicinal hemp-based drugs, as well as the existence of a number of possible regulatory bodies in the country, suggesting the need for less capital. Research has also shown the potential for treatment of some medical conditions prevalent among Ghanaians using medicinal hemp-based products. These reasons suggest that the most feasible option may be for the government to invest in medicinal hemp. Conclusion Considering the challenges associated with the development of other hemp-based products, the availability of resources in the country for exploitation of medicinal hemp, and the potential benefits of hemp-based drugs to Ghanaians, investing in medicinal hemp may be the best option for the government of Ghana.
first_indexed 2024-04-11T07:06:37Z
format Article
id doaj.art-2ca2404b187f44df8e868f0cf501989d
institution Directory Open Access Journal
issn 2522-5782
language English
last_indexed 2024-04-11T07:06:37Z
publishDate 2022-11-01
publisher BMC
record_format Article
series Journal of Cannabis Research
spelling doaj.art-2ca2404b187f44df8e868f0cf501989d2022-12-22T04:38:23ZengBMCJournal of Cannabis Research2522-57822022-11-01411610.1186/s42238-022-00167-4Ghana’s preparedness to exploit the medicinal value of industrial hempRichard Quansah Amissah0Department of Biomedical Sciences, University of GuelphAbstract Background Interest in industrial hemp is increasing steadily, as can be seen by the growing number of countries that have either decriminalized industrial hemp or are contemplating its decriminalization. In line with this trend, Ghana recently decriminalized the cultivation of industrial hemp (the cannabis variety with low Δ9-tetrahydrocannabinol (THC) and high cannabidiol (CBD) content), resulting in the need for research into its benefits to Ghanaians. This article examines cannabis (including industrial hemp) production, facilities for industrial hemp exploitation, and the potential benefits of industrial hemp in Ghana. Main body Indigenous cannabis strains in Ghana have high THC to CBD ratios suggesting the need for the government to purchase foreign hemp seeds, considering that the alternative will require significant research into decreasing the THC to CBD ratio of indigenous cannabis strains. Furthermore, there are several facilities within the country that could be leveraged for the production of medicinal hemp-based drugs, as well as the existence of a number of possible regulatory bodies in the country, suggesting the need for less capital. Research has also shown the potential for treatment of some medical conditions prevalent among Ghanaians using medicinal hemp-based products. These reasons suggest that the most feasible option may be for the government to invest in medicinal hemp. Conclusion Considering the challenges associated with the development of other hemp-based products, the availability of resources in the country for exploitation of medicinal hemp, and the potential benefits of hemp-based drugs to Ghanaians, investing in medicinal hemp may be the best option for the government of Ghana.https://doi.org/10.1186/s42238-022-00167-4Industrial hempGhanaΔ9-TetrahydrocannabinolCannabidiol
spellingShingle Richard Quansah Amissah
Ghana’s preparedness to exploit the medicinal value of industrial hemp
Journal of Cannabis Research
Industrial hemp
Ghana
Δ9-Tetrahydrocannabinol
Cannabidiol
title Ghana’s preparedness to exploit the medicinal value of industrial hemp
title_full Ghana’s preparedness to exploit the medicinal value of industrial hemp
title_fullStr Ghana’s preparedness to exploit the medicinal value of industrial hemp
title_full_unstemmed Ghana’s preparedness to exploit the medicinal value of industrial hemp
title_short Ghana’s preparedness to exploit the medicinal value of industrial hemp
title_sort ghana s preparedness to exploit the medicinal value of industrial hemp
topic Industrial hemp
Ghana
Δ9-Tetrahydrocannabinol
Cannabidiol
url https://doi.org/10.1186/s42238-022-00167-4
work_keys_str_mv AT richardquansahamissah ghanaspreparednesstoexploitthemedicinalvalueofindustrialhemp